European Medicines Agency Validates Gilead Sciences, Inc. (GILD)'s Marketing Application for Sofosbuvir for the Treatment of Hepatitis C
5/22/2013 11:16:30 AM
More...
|
European Medicines Agency Accepts Veloxis Pharmaceuticals A/S (VELO)' Marketing Authorization Application (MAA) for LCP-Tacro for Treatment of Kidney Transplant Patients
5/22/2013 9:38:02 AM
More...
|
European Medicines Agency Ordered Not to Release AbbVie (ABBV)'s Trial Data, for Now
5/1/2013 8:08:27 AM
More...
|
BioIndustry Association Comment on European Medicines Agency Interim Ruling by EU General Court
4/30/2013 10:53:25 AM
More...
|
Veloxis Pharmaceuticals A/S (VELO) Announces Submission of Marketing Authorization Application (MAA) to European Medicines Agency (EMA) for LCP-Tacro™ for Treatment of Kidney Transplant Patients
4/29/2013 10:33:21 AM
More...
|
Medivir AB (MVIRb.F): Marketing Authorization Application for Simeprevir to the European Medicines Agency for the Treatment of Patients With Genotype 1 and Genotype 4 Hepatitis C is Now Filed
4/24/2013 11:43:39 AM
More...
|
European Medicines Agency Publishes 2012 Annual Report
4/16/2013 9:48:50 AM
More...
|
European Medicines Agency Staff Push to Restrict Servier Osteoporosis Drug
4/15/2013 8:12:21 AM
More...
|
GE Healthcare Submits Application to European Medicines Agency for Its Own Manufacturing of Optison™ 0.19 mg/ml Dispersion for Injection (Human Albumin Microspheres Containing Perflutren)
3/29/2013 9:22:27 AM
More...
|
Pharming Group (PHGUF.PK) Announces European Medicines Agency Approval of New Manufacturing Site for Ruconest®
3/28/2013 9:20:58 AM
More...
|
|